Development and Evaluation of Adeno-HTLV-III Hybrid Virus and Non-Cytopathic HTLV-III Mutant for Vaccine Use
ted, our vaccination protocols have been changed to Include chiupanzees. However we feel that further characterising the African Green monkey as an alternative model is important since the chimpanzee model has several limitations. Chimpanz2es are difficult to obtain in la:ge enough numbers to cenduct a vaccination protocol. They are expensive to maintain. Although chimpanzees can be chronically infected with HIV, they remain clinically well (10). African green monkeys may prove to be a useful model since enough animals to conduct a vac-in tion trial can be obtained and maintained at a relatively low cost. Preliinary experiments with Africian green monkeys established that this species can be infected with HIV. Future experimentation revealed that using the original protocol, not all monkeys responded with full evidence of infection and an anti-HIV immune response. Full evidence of infection was defined as reverse transcriptase (RT) activity in supernatants of peripheral blood lymphocytes (PBL), immunofluorescent staining of PHA activated PBL, HIV transmission to T cells and an intergrated HIV genomic pattern southern blot DNA hybridization. Experiments to determine the protocol necessary to inaect 100% of African green monkeys were begun. Parameters studied included: a) Varying the strain of African green monkey. Three strains, Cercoithecus aethiops, C. ascarius and C. cerebs wore teated; b) Varying the HIV strain, HIV 1 and HIV 2 were tested; c) Varying the route of infection. Intravenous (IV) and intraperitoneal (IP) routes were investigated; d) Varying the number and dose of virus. We have not conducted any studies with RTLV-IIIX1O-I mutant virus since vaccination with live mutant HIV 'virus is not practical due to possibility of reversion to virulence. Therefore, the immune response to recombinant vaccinia-RHIV virus containing gene sequences to HIV gpl60 has been studied. Because T cells can play an important role in host defense againsL viral infectious t13), it is important to investigate T cell mediated immunity in "raccin&ted or infected monkeys. Both T cell mediated lysis of infected targets and antigen induced cellular proliferation have been investigated. Serological studies have also been conducted. Investigations into cytopathogenie mechanisms of MIV infection have been conducted by comparing results 7
About this Item
- Title
- Development and Evaluation of Adeno-HTLV-III Hybrid Virus and Non-Cytopathic HTLV-III Mutant for Vaccine Use
- Author
- Lubet, Martha Turner, 1950- | Dusing-Swartz, Sandra Kay
- Canvas
- Page 7
- Publication
- 1987-10-28
- Subject terms
- reports
- Series/Folder Title
- Disease Management > AIDS Vaccines > Clinical Trials > Department of Defense (U.S.)
- Item type:
- reports
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0337.008
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0337.008/14
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0337.008
Cite this Item
- Full citation
-
"Development and Evaluation of Adeno-HTLV-III Hybrid Virus and Non-Cytopathic HTLV-III Mutant for Vaccine Use." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0337.008. University of Michigan Library Digital Collections. Accessed June 22, 2025.